skip to Main Content

Signaling Mechanisms in Pancreatic Cancer Cells Could Provide New Target for Treatment

Newsfeed image, light gray text on dark gray background
Research led by scientists at the UCLA Jonsson Comprehensive Cancer Center provides new insights into molecular “crosstalk” in pancreas cancer cells.

The study, published in the journal Cell Reports, identifies vulnerabilities that could provide a target for therapeutic drugs already being studied for several different types of cancer. It was led by Dr. Caius Radu, a UCLA professor of molecular and medical pharmacology, and Dr. Timothy Donahue, a pancreatic cancer surgeon. Read more . . . 

Back To Top